UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1042) 1042
Book Chapter (30) 30
Book / eBook (6) 6
Book Review (2) 2
Dissertation (2) 2
Newspaper Article (2) 2
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (812) 812
humans (712) 712
life sciences & biomedicine (705) 705
animals (330) 330
male (308) 308
female (301) 301
macrocyclic compounds - therapeutic use (253) 253
pharmacology & pharmacy (229) 229
antiviral agents - therapeutic use (215) 215
drug therapy, combination (193) 193
hepatitis c, chronic - drug therapy (192) 192
middle aged (188) 188
lactams, macrocyclic - pharmacology (184) 184
hsp90 heat-shock proteins - antagonists & inhibitors (182) 182
carbamates - therapeutic use (181) 181
benzoquinones - pharmacology (175) 175
mice (157) 157
macrocyclic compounds - chemistry (153) 153
oncology (153) 153
uracil - analogs & derivatives (150) 150
biological and medical sciences (149) 149
sulfonamides - therapeutic use (146) 146
anilides - therapeutic use (145) 145
hepacivirus - genetics (145) 145
chemistry (141) 141
hepatitis c (141) 141
heat shock proteins (139) 139
cell line, tumor (134) 134
hepatitis c virus (134) 134
aged (132) 132
adult (131) 131
biochemistry & molecular biology (131) 131
genotype (129) 129
medical sciences (129) 129
ritonavir - therapeutic use (127) 127
treatment outcome (127) 127
physical sciences (121) 121
macrocyclic compounds - pharmacology (119) 119
proteins (116) 116
hsp90 heat-shock proteins - metabolism (113) 113
cancer (112) 112
analysis (110) 110
uracil - therapeutic use (107) 107
health aspects (100) 100
antineoplastic agents - pharmacology (97) 97
macrocyclic compounds (97) 97
gastroenterology & hepatology (95) 95
hepacivirus - drug effects (95) 95
macrocyclic compounds - administration & dosage (94) 94
ribavirin - therapeutic use (94) 94
care and treatment (93) 93
hepatitis (92) 92
pharmacology. drug treatments (91) 91
lactams, macrocyclic (89) 89
lactams, macrocyclic - therapeutic use (88) 88
antiviral agents (87) 87
sustained virologic response (85) 85
research (84) 84
benzoquinones (81) 81
macrocyclic compounds - adverse effects (81) 81
ritonavir (81) 81
antiviral agents - administration & dosage (78) 78
antiviral agents - adverse effects (77) 77
chemistry, multidisciplinary (75) 75
geldanamycin (75) 75
hepatitis c - drug therapy (74) 74
apoptosis - drug effects (73) 73
antineoplastic agents - therapeutic use (72) 72
ribavirin (72) 72
apoptosis (71) 71
carbamates - administration & dosage (71) 71
drug therapy (69) 69
tumors (69) 69
carbamates - adverse effects (68) 68
chemistry, medicinal (67) 67
hepatitis c, chronic - virology (66) 66
interferon (66) 66
benzoquinones - therapeutic use (65) 65
infectious diseases (65) 65
antineoplastic agents (64) 64
genetic aspects (62) 62
patients (62) 62
cell proliferation - drug effects (61) 61
liver (59) 59
peptides (59) 59
molecular structure (58) 58
sulfonamides - administration & dosage (58) 58
cell biology (57) 57
hsp90 (57) 57
research article (57) 57
anilides - administration & dosage (56) 56
anilides - adverse effects (56) 56
clinical trials (56) 56
infections (56) 56
sulfonamides - adverse effects (56) 56
ritonavir - administration & dosage (55) 55
sofosbuvir - therapeutic use (55) 55
dose-response relationship, drug (54) 54
pharmacology (54) 54
drug combinations (53) 53
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1075) 1075
German (9) 9
Chinese (4) 4
Japanese (4) 4
Spanish (4) 4
Czech (2) 2
French (2) 2
Hungarian (2) 2
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2017, Volume 153, Issue 1, pp. 113 - 122
Journal Article
The New England journal of medicine, ISSN 0028-4793, 06/2017, Volume 376, Issue 22, pp. 2134 - 2146
Journal Article
Journal of hepatology, ISSN 0168-8278, 09/2019, Volume 71, Issue 3, pp. 486 - 497
Journal Article
The New England journal of medicine, ISSN 0028-4793, 04/2014, Volume 370, Issue 17, pp. 1594 - 1603
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antiviral agents | Biological and medical sciences | General aspects | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Anilides - therapeutic use | Anilides - adverse effects | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Viral Load | Young Adult | Ritonavir - adverse effects | Ritonavir - therapeutic use | Adult | Female | Double-Blind Method | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Uracil - therapeutic use | Macrocyclic Compounds - adverse effects | Hepatitis C, Chronic - drug therapy | Macrocyclic Compounds - therapeutic use | Uracil - adverse effects | Sulfonamides - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Adolescent | Sulfonamides - adverse effects | Carbamates - adverse effects | Aged | Carbamates - therapeutic use | Drug Combinations | Uracil - analogs & derivatives | Dosage and administration | Research | Drug therapy, Combination | Hepatitis C | Drug therapy | Ribavirin | Ritonavir | Body weight | Diarrhea | Infections | Nausea | Proteinase inhibitors | Pruritus | Drug resistance | Patients | Genotype & phenotype | Cirrhosis | Sleep disorders | Hepatitis | Asthenia | Hemoglobin | Interferon | Drug dosages | Genotypes | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
The New England journal of medicine, ISSN 0028-4793, 04/2014, Volume 370, Issue 17, pp. 1604 - 1614
Journal Article
Head & neck, ISSN 1043-3074, 05/2012, Volume 34, Issue 5, pp. 736 - 745
epidermal growth factor (EGF) | RET | immunomodulator | vascular disrupting agent | multi‐kinase inhibitor | vascular endothelial growth factor (VEGF) | thyroid cancer | histone acetylation | B‐Raf | heat shock protein (HSP) | multi-kinase inhibitor | B-Raf | Otorhinolaryngology | Life Sciences & Biomedicine | Surgery | Science & Technology | Otorhinolaryngology. Stomatology | Malignant tumors | Pharmacology. Drug treatments | Thyroid. Thyroid axis (diseases) | Biological and medical sciences | Endocrinopathies | Medical sciences | Immunomodulators | Niacinamide - analogs & derivatives | Anilides - therapeutic use | Bibenzyls - therapeutic use | Humans | Antineoplastic Agents - therapeutic use | Benzenesulfonates - therapeutic use | Pyrazines - therapeutic use | Boronic Acids - therapeutic use | Proto-Oncogene Proteins c-kit - antagonists & inhibitors | Thalidomide - analogs & derivatives | Angiogenesis Inhibitors - therapeutic use | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Valproic Acid - therapeutic use | Depsipeptides - therapeutic use | Imidazoles - therapeutic use | Lactams, Macrocyclic - therapeutic use | Pyrroles - therapeutic use | Pyridines - therapeutic use | Bortezomib | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Piperazines - therapeutic use | Imatinib Mesylate | Sulfonamides - therapeutic use | Thyroid Neoplasms - drug therapy | HSP90 Heat-Shock Proteins - antagonists & inhibitors | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Quinazolines - therapeutic use | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Hydroxamic Acids - therapeutic use | Indoles - therapeutic use | Histone Deacetylase Inhibitors - therapeutic use | Quinolines - therapeutic use | Benzamides | Thalidomide - therapeutic use | Benzoquinones - therapeutic use | Indazoles - therapeutic use | Protein-Tyrosine Kinases - antagonists & inhibitors | Index Medicus
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2014, Volume 147, Issue 2, pp. 359 - 365.e1
Journal Article